Journal of Jilin University(Medicine Edition) ›› 2023, Vol. 49 ›› Issue (1): 122-130.doi: 10.13481/j.1671-587X.20230116
• Research in basic medicine • Previous Articles
Junyi JIN,Mu LI,Yaoyuan HU,Yihui WANG(
)
Received:2022-03-21
Online:2023-01-28
Published:2023-02-03
Contact:
Yihui WANG
E-mail:wangyihui@sj-hospital.org
CLC Number:
Junyi JIN,Mu LI,Yaoyuan HU,Yihui WANG. Targeting relationship between miR-150-5p and NCAPG and its inhibitory effect on hepatocellular carcinoma Huh7 cells[J].Journal of Jilin University(Medicine Edition), 2023, 49(1): 122-130.
Tab. 1
Primer sequences of RT-qPCR"
| Gene | Primer sequence |
|---|---|
| miR-150-5p | Forward: 5'-TCGGCGTCTCCCAACCCTTGTAC-3' Reverse: 5'-GTCGTATCCAGTGCAGGGTCCGAGGT-3' |
| NCAPG | Forward: 5'-ATTGCTTTGTATTGGTGTGCCCTTTG-3' Reverse: 5'-ACAACTGGAATGCTCTGGATGTAACTC-3' |
| GAPDH | Forward: 5'-CGGAGTCAACGGATTTGGTCGTAT-3' Reverse: 5'-AGCCTTCTCCATGGTGGTGAAGAC-3' |
| U6 | Forward: 5'-TGCGGGTGCTCGCTTCGGCAGC-3' Reverse: 5'-CCAGTGCAGGGTCCGAGGT-3' |
Tab.3
Tumor volumes of nude mice in various groups at different time (n=5,x±s, V/mm3)"
| Group | Tumor volume | ||||||
|---|---|---|---|---|---|---|---|
| (t/d) 3 | 6 | 9 | 12 | 15 | 18 | 21 | |
| AgomiR-NC | 4.18±0.87 | 8.24±1.48 | 55.35±8.77 | 98.72±21.35 | 174.25±42.88 | 382.54±87.66 | 689.09±211.94 |
| AgomiR-150-5p | 3.44±0.66 | 5.86±1.08 | 15.82±3.42* | 27.52±5.77* | 35.47±4.82* | 56.45±9.21* | 123.24±19.96* |
| AgomiR-150-5p+ovNC | 3.12±0.48 | 5.77±0.75 | 14.33±2.95 | 21.85±4.32 | 32.35±5.89 | 51.08±8.77 | 116.04±19.04 |
| AgomiR-150-5p+ovNCAPG | 4.56±0.74 | 7.52±0.98 | 28.52±1.77△ | 42.74±8.77△ | 68.75±18.72△ | 108.95±30.27△ | 229.86±81.88△ |
| 1 | SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33. |
| 2 | LIU W W, LIANG B, LIU H L, et al. Overexpression of non‑SMC condensin Ⅰ complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma[J]. Int J Mol Med, 2017, 40(3): 731-738. |
| 3 | LIU K K, LI Y M, YU B, et al. Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells[J]. Can J Physiol Pharmacol, 2018, 96(12): 1246-1254. |
| 4 | GONG C W, AI J Y, FAN Y, et al. NCAPG promotes the proliferation of hepatocellular carcinoma through PI3K/AKT signaling[J]. Onco Targets Ther, 2019, 12: 8537-8552. |
| 5 | OURA K, MORISHITA A, MASAKI T. Molecular and functional roles of microRNAs in the progression of hepatocellular carcinoma-A review[J]. Int J Mol Sci, 2020, 21(21): 8362. |
| 6 | CUI X, JIANG X Y, WEI C S, et al. Astragaloside Ⅳ suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis[J]. Environ Toxicol Pharmacol, 2020, 78: 103397. |
| 7 | BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. |
| 8 | KULIK L, EL-SERAG H B. Epidemiology and management of hepatocellular carcinoma[J]. Gastroenterology, 2019, 156(2): 477-491. |
| 9 | SCHLABE S, ROCKSTROH J K. Advances in the treatment of HIV/HCV coinfection in adults[J]. Expert Opin Pharmacother, 2018, 19(1): 49-64. |
| 10 | HUO T I, HSU C Y, LIU P H. Magic mirror on the wall: which is the best biomarker for hepatocellular carcinoma?[J]. Hepatology, 2018, 67(6): 2482-2483. |
| 11 | HARTKE J, JOHNSON M, GHABRIL M. The diagnosis and treatment of hepatocellular carcinoma[J]. Semin Diagn Pathol, 2017, 34(2): 153-159. |
| 12 | SUN J Y, YIN T L, ZHANG X Y, et al. Therapeutic advances for patients with intermediate hepatocellular carcinoma[J]. J Cell Physiol, 2019, 234(8): 12116-12121. |
| 13 | YERUKALA SATHIPATI S, HO S Y. Novel miRNA signature for predicting the stage of hepatocellular carcinoma[J].Sci Rep,2020,10(1):14452. |
| 14 | MOHAMED A A, ALI-ELDIN Z A, ELBEDEWY T A,et al. MicroRNAs and clinical implications in hepatocellular carcinoma[J]. World J Hepatol, 2017, 9(23): 1001-1007. |
| 15 | CHEN F, LI X F, FU D S, et al. Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma[J]. Cancer Biomark, 2017, 18(2): 209-214. |
| 16 | HUNG J H, LI C H, YEH C H, et al. microRNA-224 down-regulates glycine N-methyltransferase gene expression in Hepatocellular Carcinoma[J]. Sci Rep, 2018, 8(1): 12284. |
| 17 | JIANG C, HE Z L, HU X H, et al. MiRNA-15a-3p inhibits the metastasis of hepatocellular carcinoma by interacting with HMOX1[J]. Eur Rev Med Pharmacol Sci, 2020, 24(24): 12694-12700. |
| 18 | YU W S, WANG Z G, GUO R P, et al. Hepatocellular carcinoma progression is protected by miRNA-34c-5p by regulating FAM83A[J]. Eur Rev Med Pharmacol Sci, 2020, 24(11): 6046-6054. |
| 19 | CHEN X X, XU X N, PAN B, et al. miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer[J].Aging (Albany NY),2018,10(11): 3421-3437. |
| 20 | LU W, ZHANG H H, NIU Y Q, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p[J]. Mol Cancer, 2017, 16(1): 118. |
| 21 | JIANG L L, REN L L, CHEN H, et al. NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer[J]. Cell Death Dis, 2020, 11(7): 547. |
| 22 | WU Y, LIN Y, PAN J F, et al. NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway[J]. Cancer Cell Int,2021,21(1): 443. |
| 23 | WANG Y, GAO B, TAN P Y, et al. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth[J]. FASEB J, 2019, 33(8): 8759-8770. |
| 24 | GUO Z Y, ZHU Z T. NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma[J]. Eur Rev Med Pharmacol Sci, 2021, 25(23): 7238-7251. |
| 25 | AI J Y, GONG C W, WU J J, et al. microRNA‑181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG[J]. Cancer Manag Res, 2019, 11: 3455-3467. |
| [1] | Xingzhu CHEN,Mingyue YU,Shuang LIU,Jianing LI,Zunxuan XIE,Jinyao LIU,Yuyan LIU. Remineralization property of fluoride loaded poly (propylene carbonate) dental patch and its cytotoxicity on fibroblast L929 cells of mice [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1429-1436. |
| [2] | Qingyu ZHANG,Tingrui XU,Junjun JIAO,Degeng XIA,Tianyi ZHANG,Li ZHANG,Ning MA. Preparation method of platelet-rich fibrin and hydroxyapatite complex and property evaluation [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1448-1454. |
| [3] | Xianshun XIE,Wei WANG,Haibing JIANG. Effect of miR-431-3p on proliferation and apoptosis of gastric cancer cells and its mechanism of targeted regulation of CTDP1 gene expression [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1555-1565. |
| [4] | Hongxia SUN,Chunxu LIU,Xuejun AN,Guanghua CUI,Jingyu WANG,Shuangxi TONG,Xiaoqiu YANG. Effect of Schisandra chinensis polysaccharide on proliferation and apoptosis of human bladder cancer T24 cells and its mechanisms [J]. Journal of Jilin University(Medicine Edition), 2022, 48(5): 1216-1222. |
| [5] | Qian ZHANG,Jing LI. Inhibitory effect of TLR4 gene overexpression on autophagy of gastric cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(5): 1238-1246. |
| [6] | Xiaomei HUANG,Hongwei WANG,Zhenyan HAN,Qiuyuan WEI,Sujing HUANG. Effects of lncRNA GHET1 on biological behaviors of trophoblast cells in preeclampsia through Wnt/β-catenin signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2022, 48(5): 1324-1332. |
| [7] | Liantao HU,Wenjun DENG,Shizhen LU,Luo SUN,Xuebing LI,Chuhao LI,Xinran WANG,chunbing ZHANG,Yue LI,Weiqun WANG. Bioinformatics analysis on CC chemokine ligand 20 expression in hepatocellular carcinoma tissue and its effect on prognostic assessment of liver hepatocellular carcinoma [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 1010-1017. |
| [8] | Zhijuan WANG,Mingshu ZHANG,Liping YE. Effects of platelet-derived growth factor D on proliferation, migration and invasion of lung cancer H1299 cells through ERK signaling pathway and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 898-904. |
| [9] | Yandi MA,Xiangyun LU,Shangfeng HE,Xueyan YU,Yunhua HU,Haixia GAO,Yunzhao CHEN,Jie YU,Wenjie WANG,Feng LI,Xiaobin CUI. Expression of m6A methylation binding protein YTHDF2 in esophageal carcinoma tissue and its effect on proliferation and migration of esophageal carcinoma cells [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 962-970. |
| [10] | Guowu WANG,Yuan YAO,Yu ZHANG,Na XU,Fang LIU. Inhibitory effect of miR-152 on proliferation and invasion of endometrial carcinoma cells by reducing low-density lipoprotein receptor expression [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 591-599. |
| [11] | Guanhu LI,Qingxu LANG,Chunyan LIU,Qin LIU,Mengrou GENG,Xiaoqian LI,Zhenqi WANG. Inhibitory effect of valproic acid combined with X-ray irradiation on proliferation of breast cancer MDA-MB-231 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 622-629. |
| [12] | Peiyu YAN,Aichen ZHANG,Hong ZHANG,Yang LI,Mengmeng ZHANG,Mengze LUO,Ying PAN. Therapeutic effect of adipose-derived mesenchymal stem cells on premature ovarian failure model rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 648-656. |
| [13] | Cuilan LIU,Fengai HU,Jing LIU,Dan WANG,Changyun QIU,Dunjiang LIU,Di ZHAO. Effect of adiponectin receptor agonist AdiopRon on biological behaviors of glioma cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 702-710. |
| [14] | Zhuangzhi WU,Xiaoning HE,Siqi CHEN. Inhibitory effect of miR-124-3p on proliferation and invasion of oral squamous cell carcinoma cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 718-727. |
| [15] | Xiaoyan LI,Wei ZHANG,Jie HE. Promotion effect of REG1A on proliferation and migration of lung adenocarcinoma cells by regulating Wnt/β-catenin signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 444-453. |
|
||